Home › Depression › Washington
Depression clinical trials in Washington
20 studies for Depression are looking for participants at sites in Washington.
Cities in Washington
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06793397RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Seattle NTC, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06713616A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 26, 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 14, 2026 · NCT07226232A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 6, 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Aug 4, 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 3, 2026 · NCT06775379A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Core Clinical Research /ID# 226374, Everett
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Jul 27, 2026 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06966401CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Madigan Army Medical Center, Fort Lewis
Recruiting
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05663034TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Seattle Children's Hospital, Seattle
RecruitingObservational study
18 Months – 11 Years · All sexes · Updated Jul 6, 2026 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Center For Anxiety and Depression, Mercer Island
- Seattle Neuropsychiatric Treatment Center, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 11, 2026 · NCT06524830Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
Recruiting
Ages 12 to 22 · All sexes · Updated Oct 30, 2025 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jan 23, 2025 · NCT06223880Lay-Delivered Behavioral Activation in Senior Centers
- Enumclaw Senior Center, Enumclaw
- Casa Latina, Seattle
- Centro de la Raza, Seattle
- and 1 more
Recruiting
Ages 60 and older · All sexes · Updated Oct 15, 2024 · NCT04621877From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.